Repligen Corporation

NasdaqGS:RGEN Rapporto sulle azioni

Cap. di mercato: US$8.4b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Repligen Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Repligen ha un patrimonio netto totale di $2.0B e un debito totale di $587.2M, che porta il suo rapporto debito/patrimonio netto a 29.6%. Le sue attività totali e le sue passività totali sono rispettivamente $2.9B e $875.6M. L'EBIT di Repligen è $8.4M rendendo il suo rapporto di copertura degli interessi -0.7. Ha liquidità e investimenti a breve termine pari a $809.1M.

Informazioni chiave

29.6%

Rapporto debito/patrimonio netto

US$587.21m

Debito

Indice di copertura degli interessi-0.7x
ContantiUS$809.15m
Patrimonio nettoUS$1.99b
Totale passivitàUS$875.56m
Totale attivitàUS$2.86b

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Repligen Corporation (NASDAQ:RGEN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Jul 31
Repligen Corporation (NASDAQ:RGEN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

We Think Repligen (NASDAQ:RGEN) Can Stay On Top Of Its Debt

Jul 15
We Think Repligen (NASDAQ:RGEN) Can Stay On Top Of Its Debt

Repligen: Strong Filtration Growth, Offset By Other Challenges

Jul 13

Why We're Not Concerned Yet About Repligen Corporation's (NASDAQ:RGEN) 27% Share Price Plunge

Jun 14
Why We're Not Concerned Yet About Repligen Corporation's (NASDAQ:RGEN) 27% Share Price Plunge

Is Now The Time To Look At Buying Repligen Corporation (NASDAQ:RGEN)?

Jun 10
Is Now The Time To Look At Buying Repligen Corporation (NASDAQ:RGEN)?

Repligen Stock: Still Quite Overvalued

May 30

Repligen Corporation Just Missed Earnings - But Analysts Have Updated Their Models

May 03
Repligen Corporation Just Missed Earnings - But Analysts Have Updated Their Models

Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)

Apr 30
Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)

Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet

Apr 15
Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet

At US$206, Is Repligen Corporation (NASDAQ:RGEN) Worth Looking At Closely?

Feb 13
At US$206, Is Repligen Corporation (NASDAQ:RGEN) Worth Looking At Closely?

Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)

Jan 08
Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)

Why We're Not Concerned About Repligen Corporation's (NASDAQ:RGEN) Share Price

Dec 19
Why We're Not Concerned About Repligen Corporation's (NASDAQ:RGEN) Share Price

What Does Repligen Corporation's (NASDAQ:RGEN) Share Price Indicate?

Nov 01
What Does Repligen Corporation's (NASDAQ:RGEN) Share Price Indicate?

Is Repligen (NASDAQ:RGEN) Using Too Much Debt?

Oct 17
Is Repligen (NASDAQ:RGEN) Using Too Much Debt?

Is There An Opportunity With Repligen Corporation's (NASDAQ:RGEN) 22% Undervaluation?

Sep 29
Is There An Opportunity With Repligen Corporation's (NASDAQ:RGEN) 22% Undervaluation?

Things Look Grim For Repligen Corporation (NASDAQ:RGEN) After Today's Downgrade

Aug 09
Things Look Grim For Repligen Corporation (NASDAQ:RGEN) After Today's Downgrade

Does Repligen (NASDAQ:RGEN) Have A Healthy Balance Sheet?

Jul 17
Does Repligen (NASDAQ:RGEN) Have A Healthy Balance Sheet?

Is There Now An Opportunity In Repligen Corporation (NASDAQ:RGEN)?

Jul 03
Is There Now An Opportunity In Repligen Corporation (NASDAQ:RGEN)?

With EPS Growth And More, Repligen (NASDAQ:RGEN) Makes An Interesting Case

Jun 19
With EPS Growth And More, Repligen (NASDAQ:RGEN) Makes An Interesting Case

Calculating The Fair Value Of Repligen Corporation (NASDAQ:RGEN)

May 23
Calculating The Fair Value Of Repligen Corporation (NASDAQ:RGEN)

Repligen (NASDAQ:RGEN) Seems To Use Debt Quite Sensibly

Apr 11
Repligen (NASDAQ:RGEN) Seems To Use Debt Quite Sensibly

Is Now An Opportune Moment To Examine Repligen Corporation (NASDAQ:RGEN)?

Mar 28
Is Now An Opportune Moment To Examine Repligen Corporation (NASDAQ:RGEN)?

We Ran A Stock Scan For Earnings Growth And Repligen (NASDAQ:RGEN) Passed With Ease

Mar 08
We Ran A Stock Scan For Earnings Growth And Repligen (NASDAQ:RGEN) Passed With Ease

Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)

Feb 20
Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( $1.2B ) di RGEN superano le sue passività a breve termine ( $174.3M ).

Passività a lungo termine: Le attività a breve termine di RGEN ( $1.2B ) superano le sue passività a lungo termine ( $701.3M ).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: RGEN ha più liquidità del suo debito totale.

Riduzione del debito: Il rapporto debito/patrimonio netto di RGEN è aumentato da 12% a 29.6% negli ultimi 5 anni.

Copertura del debito: Il debito di RGEN è ben coperto dal flusso di cassa operativo ( 26.4% ).

Copertura degli interessi: RGEN matura più interessi di quanti ne paga, quindi la copertura dei pagamenti degli interessi non è un problema.


Bilancio


Scoprire le aziende sane